Panel Recommends Approval for Alzheimer's Drug

Breaking News: A panel of experts recommended that the FDA approve the newest experimental drug to treat Alzheimer’s disease, donanemab, made by Eli Lilly.
https://t.co/oHRuNP7jgE

Source: https://twitter.com/nytimes/status/1800275807383797914